Pucotenlimab in high microsatellite instability/mismatch repair-defificient (MSI-H/ dMMR) solid tumors: Results update from a multicenter, phase II, open-label study - Zhang, Bo; Luo, Suxia; Yin, Xianli; Li, Enxiao; Wang, Hui; He, Yifu; Liu, Zhihui; Fan, Qingxia; Liang, Xinjun; Shu, Yongqian; Liu, Yunpeng; Xu, Nong; et al. (Journal of clinical oncology, 2025)